Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients

Bone Marrow Transplantation

Volumn 39, Issue 12, 2007, Pages 775-781

  Oliveira, A L ^a   de Souza, M ^b   Carvalho Dias, V M H ^c   Ruiz, M A ^d   Silla, L ^e   Tanaka, P Yurie ^f   Simoes B P ^g   Trabasso, P ^h   Seber, A ⁱ   Lotfi, C J ^j   Zanichelli, M A ^k   Araujo, V R ^l   Godoy, C ^m   Maiolino, A ^a   Urakawa, P ^b   Cunha, C A ^c   de Souza, C A ^h   Pasquini, R ^c   Nucci, M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Hospital Amaral Carvalho   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d HOSPITAL DE BASE   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h UNIVERSITY OF CAMPINAS   (Brazil)

ⁱ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^j A C CAMARGO CANCER CENTER   (Brazil)

^k HOSPITAL BRIGADEIRO   (Brazil)

^l Departamento de Anestesia   (Brazil)

^m Hospital Araujo Jorge   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B DEOXYCHOLATE; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BRAZIL; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG CHOICE; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; GRAFT INFECTION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR;

EID: 34250188146     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705677     Document Type: Article

References (31)

1. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947-953.
2. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36: 1103-1110.
3. Sparrelid E, Hagglund H, Remberger M, Ringden O, Lonnqvist B, Ljungman P et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22: 795-800.
4. Haupt R, Romanengo M, Fears T, Viscoli C, Castagnola E. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: A 12-year experience at a single Italian institution. Eur J Cancer 2001; 37: 2413-2419.
5. Viscoli C, Castagnola E. Treatment of febrile neutropenia: What is new? Curr Opin Infect Dis 2002; 15: 377-382.
6. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999; 20: 303-316.
7. Livermore DM. Bacterial resistance: Origins, epidemiology, and impact. Clin Infect Dis 2003; 36: S11-S23.
8. Paladino JA. Economic justification of antimicrobial management programs: Implications of antimicrobial resistance. Am J Health Syst Pharm 2000; 57 (Suppl 2): S10-S12.
9. Garnica M, Oliveira AL, Nouer SA, Nucci M. Resistant Gram-negative bacteremias in hematopoietic stem cell transplant (HSCT) recipients: incidence and outcome. Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy 2004, Book of abstracts, abstract no. K-1446.
10. Gales AC, Menezes LC, Silbert S, Sader HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Antimicrob Chemother 2003; 52: 699-702.
11. Kiffer C, Hsiung A, Oplustil C, Sampaio J, Sakagami E, Turner P et al. Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: The MYSTIC Program Brazil 2003. Braz J Infect Dis 2005; 9: 216-224.
12. Mendes C, Oplustil C, Sakagami E, Turner P, Kiffer C. Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 2002. Braz J Infect Dis 2005; 9: 44-51.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 9th Informational Supplement NCCLS 1999 M100-S9.
14. Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 1990; 161: 397-401.
15. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-494.
16. Buchheidt D, Hiddemann W, Schiel X, Kremery V, Karthaus M, Donnelly JP et al. European surveillance of infections and risk factors in cancer patients. Eur J Clin Microbiol Infect Dis 1999; 18: 161-163.
17. Elouennass M, Foissaud V, Trueba F, Doghmi K, Malfuson JV, Fagot T et al. A 7-year survey of strains identified in blood cultures in a clinical hematology unit. Med Mal Infect 2004; 34: 62-69.
18. Velasco E, Byington R, Martins CA, Schirmer M, Dias LM, Goncalves VM. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2006; 25: 1-7.
19. Petrilli AS, Melaragno R, Barros KV, Silva AA, Kusano E, Ribeiro RC et al. Fever and neutropenia in children with cancer: A therapeutic approach related to the underlying disease. Pediatr Infect Dis J 1993; 12: 916-921.
20. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393-397.
21. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005; 142: 979-995.
22. Gaytan-Martinez J, Mateos-Garcia E, Sanchez-Cortes E, Gonzalez-Llaven J, Casanova-Cardiel LJ, Fuentes-Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res 2000; 31: 388-392.
23. Engels EA, Ellis CA, Supran SE, Schmid CH, Barza M, Schenkein DP et al. Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256-266.
24. Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 2003; 31: 795-801.
25. Lang A, De FG, Meyer R, Aschbacher R, Rizza F, Mayr O et al. Comparison of antimicrobial use and resistance of bacterial isolates in a haematology ward and an intensive care unit. Eur J Clin Microbiol Infect Dis 2001; 20: 657-660.
26. Spanik S, Krupova I, Trupl J, Kunova A, Novotny J, Mateicka F et al. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: A case-controlled study. J Infect Chemother 1999; 5: 180-184.
27. Nouer SA, Nucci M, de-Oliveira MP, Pellegrino FL, Moreira BM. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob Agents Chemother 2005; 49: 3663-3667.
28. Marchaim D, Lazarovitch Z, Efrati S, Dishy V, Weissgarten J, Boldur I et al. Serious consequences to the use of cephalosporins as the first line of antimicrobial therapy administered in hemodialysis units. Nephron Clin Pract 2005; 101: C58-c64.
29. Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25: 832-837.
30. Graffunder EM, Preston KE, Evans AM, Venezia RA. Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemother 2005; 56: 139-145.
31. Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89 1238-1247.